✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting · NabkaNews

← Back to headlines

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

MedPage Today·Jun 12

This story is reported by MedPage Today. Read what other outlets are saying below, then open the original report for full details.

Full coverage

FDA Panel Endorses Capivasertib Use in Prostate Cancer

MedPage Today·May 1

Akeega Approved for BRCA2-Mutated Prostate Cancer

MedPage Today·Dec 15

MRI Before Treatment Could Provide Prognostic Information in Prostate Cancer

MedPage Today·Apr 2

FDA OKs Blood-Based Test to Help Detect High-Grade Prostate Tumors

MedPage Today·Dec 1

The Vasectomy Conversation: Guideline Reflects Changes in Patients, Talking Points

MedPage Today·Mar 25

FDA Takes Steps to Expand Testosterone for Men's Libido

MedPage Today·Apr 21

FDA Approves IV Antibiotic for Complicated UTIs

MedPage Today·Nov 4

Expand Labeling for Testosterone Replacement Therapy, FDA Panel Says

MedPage Today·Dec 11

View original report at MedPage Today ↗